IL6ST and cancer: Silencing of the CMA receptor LAMP2A increased the levels of both proteins without changes in mRNA expression, and further analysis demonstrated that YAP1 and IL6ST were direct CMA substrates, revealing a novel mechanism that controls the expression of two cancer-relevant proteins.